Dr. Pinakin Davey.

ST. LOUIS—EyePromise, a provider of evidence-based nutritional supplements for eye health, announced the appointment of Dr. Pinakin Davey as its new chief medical and science officer. Dr. Davey brings a wealth of experience and expertise in optometry, clinical research and nutritional science to further enhance EyePromise's commitment to advancing eye health through innovative solutions. As the chief medical and science officer, Dr. Davey will play a pivotal role in shaping and driving EyePromise’s scientific and medical initiatives.

His responsibilities will include overseeing the development and clinical evaluation of EyePromise's nutritional products and technology, collaborating with renowned experts in the field, and guiding the company's research and development efforts. Dr. Davey will also remain in his current position as a tenured professor at Western University of Health Sciences, College of Optometry.

Dr. Davey holds a Doctor of Optometry degree from Southern College of Optometry and a PhD from Anglia Ruskin University in Cambridge, England, in corneal biomechanics and its influence on glaucoma related measurements. His post-doctoral research fellowship at the University of Louisville for three years was focused on improving imaging techniques in glaucoma.
 
 
He has authored over 75 international publications and has given over 500 conference and invited presentations both nationally and internationally. Dr. Davey’s research area is focused on retinal and optic nerve physiology and research methods of improving vision in patients with glaucoma and macular degeneration. He is a fellow of American Academy of Optometry (AAO), a fellow of Association for Research in Vision and Ophthalmology (ARVO), a member of Optometric Glaucoma Society (OGS) and the American Optometric Association (AOA).

"I am thrilled to be joining EyePromise and working alongside such a talented team," said Dr. Davey. "I have long been impressed by EyePromise and its co-founder Dr. Dennis Gierhart’s commitment to providing science-backed nutritional solutions for eye health. I look forward to contributing my expertise to drive innovation, further expand the broadest product portfolio on the market, and improve the lives of individuals worldwide by educating on our measurable ocular nutrition solutions for optimal vision.

It’s an exciting time to be a part of the EyePromise team as they successfully launch the industry leading Zx Pro, a diagnostic macular pigment optical density (MPOD) tool designed to measure and track MPOD values."

"We are thrilled to welcome Dr. Davey to EyePromise as our chief medical and science officer," said Andreas Wolf, president of EyePromise. "His deep knowledge of medical optometry, clinical research, and nutrition will greatly strengthen our scientific foundation and accelerate our mission of providing innovative solutions for eye health. We are confident that Dr. Davey's expertise and leadership will guide us toward new breakthroughs and further establish EyePromise as the trusted authority in the field."